CY1109941T1 - ΕΝΑ ΓΟΝΙΔΙΟ ΠΟΥ ΚΩΔΙΚΟΠΟΙΕΙ ΕΝΑ ΟΜΟΛΟΓΟ ΑΝΘΡΩΠΙΝΗΣ Ρ-ΓΛΥΚΟΠΡΩΤΕΙΝΗΣ ΜΕ ΑΝΘΕΚΤΙΚΟΤΗΤΑ ΑΠΕΝΑΝΤΙ ΣΕ ΠΟΛΛΑ ΦΑΡΜΑΚΑ ΠΑΝΩ ΣΤΟ ΧΡΩΜΟΣΩΜΑ 7p15-21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥ - Google Patents

ΕΝΑ ΓΟΝΙΔΙΟ ΠΟΥ ΚΩΔΙΚΟΠΟΙΕΙ ΕΝΑ ΟΜΟΛΟΓΟ ΑΝΘΡΩΠΙΝΗΣ Ρ-ΓΛΥΚΟΠΡΩΤΕΙΝΗΣ ΜΕ ΑΝΘΕΚΤΙΚΟΤΗΤΑ ΑΠΕΝΑΝΤΙ ΣΕ ΠΟΛΛΑ ΦΑΡΜΑΚΑ ΠΑΝΩ ΣΤΟ ΧΡΩΜΟΣΩΜΑ 7p15-21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥ

Info

Publication number
CY1109941T1
CY1109941T1 CY20101100281T CY101100281T CY1109941T1 CY 1109941 T1 CY1109941 T1 CY 1109941T1 CY 20101100281 T CY20101100281 T CY 20101100281T CY 101100281 T CY101100281 T CY 101100281T CY 1109941 T1 CY1109941 T1 CY 1109941T1
Authority
CY
Cyprus
Prior art keywords
hours
glycoprotein
many drugs
over
human
Prior art date
Application number
CY20101100281T
Other languages
English (en)
Inventor
Markus H Frank
Mohamed H Sayegh
Original Assignee
The Brigham And Women´S Hospital, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by The Brigham And Women´S Hospital, Inc. filed Critical The Brigham And Women´S Hospital, Inc.
Publication of CY1109941T1 publication Critical patent/CY1109941T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2317/00—Immunoglobulins specific features
    • C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
    • C07K2317/34—Identification of a linear epitope shorter than 20 amino acid residues or of a conformational epitope defined by amino acid residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Cell Biology (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)

Abstract

Η εφεύρεση αναφέρεται σε μία Ρ-γλυκοπρωτεΐνη της οικογένειας MDR που βρίσκεται πάνω στο ανθρώπινο χρωμόσωμα 7p 15-21, πολυνουκλεοτιδικές αλληλουχίες που κωδικοποιούν αυτή την Ρ-γλυκοπρωτείνη και θραύσματα αυτών. Αυτό το γονίδιο χρησιμοποιείται σε μεθόδους για τον προσδιορισμό της ευπάθειας των καρκινοκυττάρων σε θεραπείες κατευθυνόμενες ενάντια στην αντίσταση σε πολλά φάρμακα, και για το σχεδιασμό διαγνωστικών και θεραπευτικών μεθόδων που σχετίζονται με την αντίσταση σε πολλά φάρμακα για τον καρκίνο. Η εφεύρεση αναφέρεται επίσης σε μεθόδους για τον προσδιορισμό του κατά πόσον μία δοκιμαστική ένωση μπορεί ν' αναστείλει την ανθεκτικότητα απέναντι σε πολλά φάρμακα.
CY20101100281T 2000-06-05 2010-03-23 ΕΝΑ ΓΟΝΙΔΙΟ ΠΟΥ ΚΩΔΙΚΟΠΟΙΕΙ ΕΝΑ ΟΜΟΛΟΓΟ ΑΝΘΡΩΠΙΝΗΣ Ρ-ΓΛΥΚΟΠΡΩΤΕΙΝΗΣ ΜΕ ΑΝΘΕΚΤΙΚΟΤΗΤΑ ΑΠΕΝΑΝΤΙ ΣΕ ΠΟΛΛΑ ΦΑΡΜΑΚΑ ΠΑΝΩ ΣΤΟ ΧΡΩΜΟΣΩΜΑ 7p15-21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥ CY1109941T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US20891300P 2000-06-05 2000-06-05
EP01941884A EP1290028B1 (en) 2000-06-05 2001-06-05 A GENE ENCODING A MULTIDRUG RESISTANCE HUMAN P-GLYCOPROTEIN HOMOLOGUE ON CHROMOSOME 7p15-21 AND USES THEREOF

Publications (1)

Publication Number Publication Date
CY1109941T1 true CY1109941T1 (el) 2014-09-10

Family

ID=22776565

Family Applications (2)

Application Number Title Priority Date Filing Date
CY20101100281T CY1109941T1 (el) 2000-06-05 2010-03-23 ΕΝΑ ΓΟΝΙΔΙΟ ΠΟΥ ΚΩΔΙΚΟΠΟΙΕΙ ΕΝΑ ΟΜΟΛΟΓΟ ΑΝΘΡΩΠΙΝΗΣ Ρ-ΓΛΥΚΟΠΡΩΤΕΙΝΗΣ ΜΕ ΑΝΘΕΚΤΙΚΟΤΗΤΑ ΑΠΕΝΑΝΤΙ ΣΕ ΠΟΛΛΑ ΦΑΡΜΑΚΑ ΠΑΝΩ ΣΤΟ ΧΡΩΜΟΣΩΜΑ 7p15-21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥ
CY181100185T CY1121053T1 (el) 2000-06-05 2018-02-14 Ενα γονιδιο που κωδικοποιει ενα ομολογο ανθρωπινης ρ-γλυκοπρωτεϊνης με ανθεκτικοτητα απεναντι σε πολλαπλα φαρμακα πανω στο χρωμοσωμα 7p15-21 και χρησεις αυτου

Family Applications After (1)

Application Number Title Priority Date Filing Date
CY181100185T CY1121053T1 (el) 2000-06-05 2018-02-14 Ενα γονιδιο που κωδικοποιει ενα ομολογο ανθρωπινης ρ-γλυκοπρωτεϊνης με ανθεκτικοτητα απεναντι σε πολλαπλα φαρμακα πανω στο χρωμοσωμα 7p15-21 και χρησεις αυτου

Country Status (11)

Country Link
US (6) US6846883B2 (el)
EP (5) EP3333182A1 (el)
AT (1) ATE452909T1 (el)
CA (1) CA2411101C (el)
CY (2) CY1109941T1 (el)
DE (1) DE60140868D1 (el)
DK (4) DK2298799T3 (el)
ES (4) ES2338756T3 (el)
HK (2) HK1143823A1 (el)
PT (4) PT1290028E (el)
WO (1) WO2001094400A2 (el)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2338756T3 (es) 2000-06-05 2010-05-12 The Brigham And Women's Hospital, Inc. Un gen que codifica un homologo de glicoproteina p humana multifarmaco-resistente en el cromosoma 7p15-21 y usos del mismo.
WO2003025174A2 (en) * 2001-09-06 2003-03-27 Bayer Healthcare Ag Regulation of human mrp1-like protein
PL2772535T3 (pl) 2006-05-31 2022-09-05 Children's Medical Center Corporation Mezenchymalne komórki macierzyste ABC5 dodatnie jako immunomodulatory
PT2155248E (pt) 2007-04-12 2015-10-23 Brigham & Womens Hospital Direcionamento a abcb5 para tratameto do cancro
US11542328B2 (en) 2008-11-14 2023-01-03 The Brigham And Women's Hospital, Inc. Therapeutic and diagnostic methods relating to cancer stem cells
ES2796111T3 (es) 2008-11-14 2020-11-25 Brigham & Womens Hospital Inc Métodos terapéuticos relacionados con células madre cancerosas
JP7027026B2 (ja) 2013-02-19 2022-03-01 ザ チルドレンズ メディカル センター コーポレーション 眼疾患を処置するためのａｂｃｂ５（＋）幹細胞
KR102319899B1 (ko) 2013-05-10 2021-11-01 칠드런'즈 메디컬 센터 코포레이션 상처 치유 및 조직 공학
CA3030603A1 (en) * 2016-07-14 2018-01-18 University Of Southern California Methods and composition for producing and using immune cells and stem cells for cell-based therapies
CA3181591A1 (en) * 2020-04-30 2021-11-04 Children's Medical Center Corporation Antibodies specific to abcb5 and uses thereof

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3587465T2 (de) * 1984-09-10 1994-01-20 Hsc Res Dev Corp Vielfache Drogen-Resistenz in Säugetierzellinien und Isolierung der determinanten Glykoprotein-DNS.
US4837306A (en) * 1985-02-25 1989-06-06 The Ontario Cancer Institute Method for selecting hybridomas producing antibodies specific to the P-glycoprotein cell suface antigen and a cDNA clone encoding the C-terminal portion of the antigen
US5693622A (en) 1989-03-21 1997-12-02 Vical Incorporated Expression of exogenous polynucleotide sequences cardiac muscle of a mammal
US5399483A (en) * 1989-03-30 1995-03-21 Suntory Limited Expression of MDR-related gene in yeast cell
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
US5434075A (en) * 1992-03-20 1995-07-18 Board Of Trustees Of The University Of Illinois Monoclonal antibody to a human MDR1 multidrug resistance gene product, and uses
IT1257893B (it) * 1992-06-17 1996-02-16 Ist Superiore Sanita Anticorpi monoclonali che riconoscono un epitopo della p-glicoproteina umana.
WO1994009363A1 (en) * 1992-10-14 1994-04-28 Board Of Regents, The University Of Texas System Cancer diagnosis and therapy
JP4073961B2 (ja) 1996-10-01 2008-04-09 協和醗酵工業株式会社 含窒素複素環化合物
US6020191A (en) 1997-04-14 2000-02-01 Genzyme Corporation Adenoviral vectors capable of facilitating increased persistence of transgene expression
US6008002A (en) * 1997-09-29 1999-12-28 Bodey; Bela Immunomagnetic detection and isolation of cancer cells
ATE315088T1 (de) * 1998-02-05 2006-02-15 Glaxosmithkline Biolog Sa Tumorassoziierte antigenderivate der mage-familie,nukleinsäuresequenzen die dafür kodieren, zur herstellung von fusionsproteinen und zusammensetzungen zur impfung
WO1999046366A1 (en) 1998-03-13 1999-09-16 Osiris Therapeutics, Inc. Uses for humane non-autologous mesenchymal stem cells
JP2003510071A (ja) * 1999-09-28 2003-03-18 ジェンテスト・コーポレーション Ｐ−糖タンパク質およびその使用
AU3087801A (en) * 2000-02-04 2001-08-14 Molecular Dynamics Inc Human genome-derived single exon nucleic acid probes useful for analysis of geneexpression in human breast and hbl 100 cells
ES2338756T3 (es) 2000-06-05 2010-05-12 The Brigham And Women's Hospital, Inc. Un gen que codifica un homologo de glicoproteina p humana multifarmaco-resistente en el cromosoma 7p15-21 y usos del mismo.
PL208113B1 (pl) 2000-06-22 2011-03-31 Genentech Inc Agonistyczne przeciwciało monoklonalne anty-trkC, mysie agonistyczne przeciwciało monoklonalne, ludzkie agonistyczne przeciwciało monoklonalne, wyizolowana cząsteczka kwasu nukleinowego kodująca mysie agonistyczne przeciwciało monoklonalne, wyizolowana cząsteczka kwasu nukleinowego kodująca ludzkie przeciwciało anty-trkC, cząsteczka kwasu nukleinowego, linia komórek gospodarza, linia komórek hybrydomy, przeciwciało wytwarzane przez tę linię komórek hybrydomy, wyizolowana cząsteczka kwasu nukleinowego i wektor zawierający tę cząsteczkę kwasu nukleinowego, przeciwciało, polipeptyd, kompozycja
CA2427010A1 (en) * 2000-10-27 2002-05-23 Incyte Genomics, Inc. Transporters and ion channels
AU2004295680A1 (en) * 2003-11-24 2005-06-16 The Rockefeller University A method for isolating a self-renewing, multipotent slow-cycling cell
US20050186672A1 (en) 2004-01-27 2005-08-25 Reliance Life Sciences Pvt. Ltd. Tissue system with undifferentiated stem cells derived from corneal limbus
CA2629330C (en) 2004-11-12 2018-05-22 Cambridge University Technical Services Ltd. Methods and means related to cancer stem cells
WO2006103685A2 (en) 2005-03-28 2006-10-05 Vision Research Foundation A method for cultivating cells derived from corneal limbal tissue and cells deived from corneal limbal tissue
WO2006138275A2 (en) 2005-06-13 2006-12-28 The Regents Of The University Of Michigan Compositions and methods for treating and diagnosing cancer
PL2772535T3 (pl) 2006-05-31 2022-09-05 Children's Medical Center Corporation Mezenchymalne komórki macierzyste ABC5 dodatnie jako immunomodulatory
EP2526969A1 (en) * 2006-09-07 2012-11-28 Stemline Therapeutics, Inc. Monitoring cancer stem cells
PT2155248E (pt) 2007-04-12 2015-10-23 Brigham & Womens Hospital Direcionamento a abcb5 para tratameto do cancro
ES2796111T3 (es) 2008-11-14 2020-11-25 Brigham & Womens Hospital Inc Métodos terapéuticos relacionados con células madre cancerosas
JP7027026B2 (ja) 2013-02-19 2022-03-01 ザ チルドレンズ メディカル センター コーポレーション 眼疾患を処置するためのａｂｃｂ５（＋）幹細胞
KR102319899B1 (ko) 2013-05-10 2021-11-01 칠드런'즈 메디컬 센터 코포레이션 상처 치유 및 조직 공학

Also Published As

Publication number Publication date
DK2298799T3 (en) 2018-02-19
EP2182005A1 (en) 2010-05-05
WO2001094400A3 (en) 2002-07-04
PT1290028E (pt) 2010-03-12
DK2182005T3 (en) 2015-06-29
ATE452909T1 (de) 2010-01-15
US20050049185A1 (en) 2005-03-03
HK1257165A1 (zh) 2019-10-18
CA2411101A1 (en) 2001-12-13
HK1143823A1 (en) 2011-01-14
EP2230253A1 (en) 2010-09-22
US9561264B2 (en) 2017-02-07
EP2182005B1 (en) 2015-03-25
US20100145030A1 (en) 2010-06-10
ES2338756T3 (es) 2010-05-12
PT2298799T (pt) 2018-02-16
EP3333182A1 (en) 2018-06-13
WO2001094400A2 (en) 2001-12-13
EP1290028A2 (en) 2003-03-12
US7465554B2 (en) 2008-12-16
US8076091B2 (en) 2011-12-13
EP1290028B1 (en) 2009-12-23
ES2434721T3 (es) 2013-12-17
US20120034196A1 (en) 2012-02-09
EP2230253B1 (en) 2013-08-07
DK1290028T3 (da) 2010-04-26
DE60140868D1 (de) 2010-02-04
US20090162873A1 (en) 2009-06-25
DK2230253T3 (da) 2013-11-18
CY1121053T1 (el) 2019-12-11
US20130287785A1 (en) 2013-10-31
EP2298799A1 (en) 2011-03-23
US6846883B2 (en) 2005-01-25
EP2298799B1 (en) 2017-11-15
US20020037522A1 (en) 2002-03-28
PT2230253E (pt) 2013-11-11
PT2182005E (pt) 2015-07-20
CA2411101C (en) 2018-01-16
US8507273B2 (en) 2013-08-13
US8425876B2 (en) 2013-04-23
ES2540102T3 (es) 2015-07-08
ES2659877T3 (es) 2018-03-19

Similar Documents

Publication Publication Date Title
CY1109941T1 (el) ΕΝΑ ΓΟΝΙΔΙΟ ΠΟΥ ΚΩΔΙΚΟΠΟΙΕΙ ΕΝΑ ΟΜΟΛΟΓΟ ΑΝΘΡΩΠΙΝΗΣ Ρ-ΓΛΥΚΟΠΡΩΤΕΙΝΗΣ ΜΕ ΑΝΘΕΚΤΙΚΟΤΗΤΑ ΑΠΕΝΑΝΤΙ ΣΕ ΠΟΛΛΑ ΦΑΡΜΑΚΑ ΠΑΝΩ ΣΤΟ ΧΡΩΜΟΣΩΜΑ 7p15-21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΟΥ
Fardi et al. The crucial role of ZEB2: from development to epithelial‐to‐mesenchymal transition and cancer complexity
Tyler Chromatin assembly: Cooperation between histone chaperones and ATP‐dependent nucleosome remodeling machines
DE60126592D1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
HUP9902571A2 (hu) Timidin kináz variánsai, ezeket kódoló nukleinsav-szekvenciák és alkalmazásuk génterápiában
DE69738581D1 (de) Menschliche dnase i hyperaktive varianten
CY1107715T1 (el) Διαγνωση και αγωγη του καρκινου του προστατη
DE69717664D1 (de) Protein e25a, methoden zu dessen herstellung und anwendung
US20140179619A1 (en) Polypeptide, nucleotide sequence thereof, and method for using the same for preventing dna synthesis and inhibiting cell proliferation
Koh et al. Brain somatic mutations in epileptic disorders
Boulay et al. Loss of heterozygosity of TRIM3 in malignant gliomas
WO2020252298A1 (en) Compositions and methods for targeting the nucleosome remodeling and deacetylase complex
Langouët et al. Mutations in BCOR, a co-repressor of CRX/OTX2, are associated with early-onset retinal degeneration
HUP9801681A2 (hu) Mutáns proteinek
CY1114585T1 (el) ΑΝΤΙΣΩΜΑΤΑ ΚΑΤΑ ΕΝΟΣ ΟΜΟΛΟΓΟΥ ΤΗΣ MDR p-ΓΛΥΚΟΠΡΩΤΕΪΝΗΣ ΕΠΑΝΩ ΣΤΟ ΧΡΩΜΟΣΩΜΑ 7p15-21 ΚΑΙ ΧΡΗΣΕΙΣ ΑΥΤΩΝ
HUP9702147A2 (hu) Humán DNáz I variánsok
Zhang et al. The expanding Mi-2/NuRD complexes: a schematic glance
ATE477815T1 (de) Verwendung von alkyltransferasen zur gentherapie um gegen die toxizität von therapeutischen alkylierungsmitteln zu schützen
Kirino et al. Genetic aspect of Hirschsprung’s disease
Deng et al. Oncofusion-driven de novo enhancer assembly promotes malignancy in Ewing sarcoma via aberrant expression of the stereociliary protein LOXHD1
ATE230027T1 (de) Menschliche dnase i varianten
PT914417E (pt) Dnase ii humana
Wachtel et al. Functional Classification of Fusion Proteins in Sarcoma
Klimov et al. Genomic organisation and tissue specific expression of ABLIM2 gene in human, mouse and rat
Winawer et al. A locus on mouse Ch10 influences susceptibility to limbic seizure severity: fine mapping and in silico candidate gene analysis